Long-Term Follow-Up Study of Patients Receiving ATL001

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 18, 2023

Study Completion Date

October 18, 2023

Conditions

MelanomaAdvanced Non Small Cell Lung Cancer

Interventions

OTHER

Biological: ATL001

No investigational product will be administered

Trial Locations (1)

University College London Hospital (UCLH) NHS Foundation Trust, University College Hospital, London